Literature DB >> 23406172

Genetic determinants of haemolysis in sickle cell anaemia.

Jacqueline N Milton1, Helen Rooks, Emma Drasar, Elizabeth L McCabe, Clinton T Baldwin, Efi Melista, Victor R Gordeuk, Mehdi Nouraie, Gregory R Kato, Gregory J Kato, Caterina Minniti, James Taylor, Andrew Campbell, Lori Luchtman-Jones, Sohail Rana, Oswaldo Castro, Yingze Zhang, Swee Lay Thein, Paola Sebastiani, Mark T Gladwin, Martin H Steinberg.   

Abstract

Haemolytic anaemia is variable among patients with sickle cell anaemia and can be estimated by reticulocyte count, lactate dehydrogenase, aspartate aminotransferase and bilirubin levels. Using principal component analysis of these measurements we computed a haemolytic score that we used as a subphenotype in a genome-wide association study. We identified in one cohort and replicated in two additional cohorts the association of a single nucleotide polymorphism in NPRL3 (rs7203560; chr16p13·3) (P = 6·04 × 10(-07) ). This association was validated by targeted genotyping in a fourth independent cohort. The HBA1/HBA2 regulatory elements, hypersensitive sites (HS)-33, HS-40 and HS-48 are located in introns of NPRL3. Rs7203560 was in perfect linkage disequilibrium (LD) with rs9926112 (r(2)  = 1) and in strong LD with rs7197554 (r(2)  = 0·75) and rs13336641 (r(2)  = 0·77); the latter is located between HS-33 and HS-40 sites and next to a CTCF binding site. The minor allele for rs7203560 was associated with the -∝(3·7) thalassaemia gene deletion. When adjusting for HbF and ∝ thalassaemia, the association of NPRL3 with the haemolytic score was significant (P = 0·00375) and remained significant when examining only cases without gene deletion∝ thalassaemia (P = 0·02463). Perhaps by independently down-regulating expression of the HBA1/HBA2 genes, variants of the HBA1/HBA2 gene regulatory loci, tagged by rs7203560, reduce haemolysis in sickle cell anaemia.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406172      PMCID: PMC4129543          DOI: 10.1111/bjh.12245

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  35 in total

1.  Proposal for a certified standard for use in hemoglobinometry; second and final report.

Authors:  R K CANNAN
Journal:  J Lab Clin Med       Date:  1958-09

Review 2.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

3.  VISTA : visualizing global DNA sequence alignments of arbitrary length.

Authors:  C Mayor; M Brudno; J R Schwartz; A Poliakov; E M Rubin; K A Frazer; L S Pachter; I Dubchak
Journal:  Bioinformatics       Date:  2000-11       Impact factor: 6.937

4.  alpha-Globin gene organisation in blacks precludes the severe form of alpha-thalassaemia.

Authors:  A M Dozy; Y W Kan; S H Embury; W C Mentzer; W C Wang; B Lubin; J R Davis; H M Koenig
Journal:  Nature       Date:  1979-08-16       Impact factor: 49.962

Review 5.  Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene.

Authors:  M H Steinberg; S H Embury
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

6.  The cooperative study of sickle cell disease: review of study design and objectives.

Authors:  M Gaston; W F Rosse
Journal:  Am J Pediatr Hematol Oncol       Date:  1982

7.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

Review 8.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

9.  Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.

Authors:  Victor R Gordeuk; Andrew Campbell; Sohail Rana; Mehdi Nouraie; Xiaomei Niu; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; Onyinye Onyekwere; Tatiana Ammosova; Sergei Nekhai; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

10.  A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

Authors:  Jacqueline N Milton; Paola Sebastiani; Nadia Solovieff; Stephen W Hartley; Pallav Bhatnagar; Dan E Arking; Daniel A Dworkis; James F Casella; Emily Barron-Casella; Christopher J Bean; W Craig Hooper; Michael R DeBaun; Melanie E Garrett; Karen Soldano; Marilyn J Telen; Allison Ashley-Koch; Mark T Gladwin; Clinton T Baldwin; Martin H Steinberg; Elizabeth S Klings
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  20 in total

Review 1.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

Review 2.  Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.

Authors:  Steven R Goodman; Betty S Pace; Kirk C Hansen; Angelo D'alessandro; Yang Xia; Ovidiu Daescu; Stephen J Glatt
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

3.  Haemolysis in sickle cell anaemia: effects of polymorphisms in α-globin gene regulatory elements.

Authors:  Jacqueline N Milton; Elmutaz M Shaikho; Martin H Steinberg
Journal:  Br J Haematol       Date:  2019-03-10       Impact factor: 6.998

Review 4.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

5.  Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.

Authors:  Charles T Quinn; Eric P Smith; Shahriar Arbabi; Paramjit K Khera; Christopher J Lindsell; Omar Niss; Clinton H Joiner; Robert S Franco; Robert M Cohen
Journal:  Am J Hematol       Date:  2016-11-08       Impact factor: 10.047

Review 6.  Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.

Authors:  Emmanuel Peprah; Huichun Xu; Fasil Tekola-Ayele; Charmaine D Royal
Journal:  Public Health Genomics       Date:  2014-11-26       Impact factor: 2.000

7.  Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease.

Authors:  Tamir Kanias; Derek Sinchar; David Osei-Hwedieh; Jeffrey J Baust; Andrew Jordan; James C Zimring; Hayley R Waterman; Karen S de Wolski; Jason P Acker; Mark T Gladwin
Journal:  Transfusion       Date:  2016-08-09       Impact factor: 3.157

Review 8.  Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.

Authors:  Alawi Habara; Martin H Steinberg
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-01

9.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

10.  Biomarker signatures of sickle cell disease severity.

Authors:  Mengtian Du; Sarah Van Ness; Victor Gordeuk; Sayed M Nouraie; Sergei Nekhai; Mark Gladwin; Martin H Steinberg; Paola Sebastiani
Journal:  Blood Cells Mol Dis       Date:  2018-05-16       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.